Skip to main content
Fig. 9 | Journal of Translational Medicine

Fig. 9

From: Analysis and validation of m6A regulatory network: a novel circBACH2/has-miR-944/HNRNPC axis in breast cancer progression

Fig. 9

CircBACH2/ has-miR-944/HNRNPC axis regulated BC progression via the MAPK signaling pathway. Western blot analysis of the protein levels of t-ErK and t-MAPK, and the protein phosphorylation levels of p-ErK and p-MAPK in MDA-MB-231 cell (A) and MCF-7 cell (B) after transfection with si-circBACH2 alone, has-miR-944 inhibitor alone, and si-circBACH2 + has-miR-944 inhibitor group. *P < 0.05 vs. siRNA negative control. C The illustration of m6A modulators in m6A modification and the potential regulatory mechanisms of the circBACH2/has-miR-944/HNRNPC axis in BC proliferation and progression

Back to article page